drugset / Trial / NCT02658838
The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-08
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | — | — |
| Background | Ticagrelor | Small molecule | — | — |
Indications
No indication recorded.